Does Dr. JACQUES ABI RACHED have financial conflicts of interest?

Dr. JACQUES ABI RACHED (MD) has received a total of $3,166 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,166 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JACQUES ABI RACHED?

According to CMS Open Payments data, Dr. JACQUES ABI RACHED received funding from BARD PERIPHERAL VASCULAR ($1,962), MEDTRONIC ($1,189), and ASTRAZENECA PHARMACEUTICALS ($15).

Does Dr. JACQUES ABI RACHED receive research grants or speaking fees?

Dr. JACQUES ABI RACHED has received $3,166 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JACQUES ABI RACHED

MDReal-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: BALTIMORE, MD 21236

NPI Number: 1790920577

LIFETIME INDUSTRY VALUE

$3,166

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABI RACHED is a verified Internal Medicine, Nephrology practitioner based in BALTIMORE, MD.

Between 2021 and 2024, Dr. ABI RACHED had an overall industry promotional and research financial footprint of $3,166 as recorded in the federal CMS Open Payments database.

$3,166 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABI RACHED's primary funding source is BARD PERIPHERAL VASCULAR, which accounts for $1,962 (representing 62% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BARD PERIPHERAL VASCULAR

Rank 1

$1,962

62%

MEDTRONIC

Rank 2

$1,189

37.5%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$15

0.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.